Point of Care Testing Market to reach US$ 36 Billion by 2024
For more Info: https://www.renub.com/point-of-care-testing-market-nd.php Point of care testing (POCT), also known as bedside testing is a medical diagnostic testing that allows patient diagnoses on the field, in the ambulance, at the physician’s office, in the hospital, or at home. The results of the point of care testing are timely and accurate which allow rapid treatment to the patient. Point of care testing has the potential to widely impact the health care delivery system by addressing the challenges of health disparities in real time. The success of the potential shift from remedial medicine to modified, prognostic and preventive medicine could rely on the enhancement of portable monitoring and diagnostic devices for point of care testing. Point of Care Testing Market is projected to reach US$ 36 Billion by the end of year 2024. Request a free sample copy of the report: https://www.renub.com/contactus.php Point of care testing is essential for the rapid detection of analytes at the patient’s site, in order to facilitate better disease diagnosis, monitoring and management. Point of care testing, the diseases can be diagnosed at a very early stage which not only enables health experts to take quick medical decisions, but also improves patient’s health by enabling the early start of treatment. Point of care testing has witnessed a tremendous advancement in the recent time. Some of them include developments in the biosensors, assay formats, microfluidic, lab-on-a-chip technologies, bioanalytical platforms and complementary technologies. Today, Point of care testing systems offers a wide range of tests menu and can transmit tests results wirelessly to the patient’s medical record for doctor review.
★
★
★
★
★
179 views • 10 slides
